Market Cap | 16.61B | P/E | 47.04 | EPS this Y | 36.10% | Ern Qtrly Grth | 2,123.20% |
Income | 359.24M | Forward P/E | 25.56 | EPS next Y | 14.20% | 50D Avg Chg | - |
Sales | 5.88B | PEG | 1.65 | EPS past 5Y | - | 200D Avg Chg | 5.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | 17.67% | 52W High Chg | - |
Recommedations | 3.00 | Quick Ratio | 1.16 | Shares Outstanding | 351.40M | 52W Low Chg | 50.00% |
Insider Own | 22.53% | ROA | 6.39% | Shares Float | 117.84M | Beta | - |
Inst Own | 79.44% | ROE | - | Shares Shorted/Prior | 15.38M/16.20M | Price | 47.28 |
Gross Margin | 66.54% | Profit Margin | 6.19% | Avg. Volume | 1,451,039 | Target Price | 47.14 |
Oper. Margin | 11.37% | Earnings Date | Feb 21 | Volume | 1,868,187 | Change | 0.00% |
PPD, Inc., together with its subsidiaries, provides drug development services to the biopharmaceutical industry worldwide. The company operates through two segments, Clinical Development Services and Laboratory Services. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri-and post-approval, and medical communications services. The company also provides laboratory services comprising bioanalytical, biomarker, vaccine science, good manufacturing practice, and central laboratory services. It serves pharmaceutical, biotechnology, medical device, and government organizations, as well as other industry participants. The company has a collaboration with Science 37 to design, build, test, implement, and execute digital trials using Science 37's DCT SaaS-based technology platform. PPD, Inc. was founded in 1985 and is headquartered in Wilmington, North Carolina. As of December 8, 2021, PPD, Inc. operates as a subsidiary of Thermo Fisher Scientific Inc.
JP Morgan | Neutral | Apr 28, 21 |
Jefferies | Hold | Apr 20, 21 |
Citigroup | Neutral | Apr 19, 21 |
Credit Suisse | Neutral | Apr 19, 21 |
Truist Securities | Hold | Apr 16, 21 |
Deutsche Bank | Hold | Apr 16, 21 |
William Blair | Market Perform | Apr 16, 21 |
Keybanc | Sector Weight | Apr 16, 21 |
Baird | Neutral | Apr 15, 21 |